DE602006001579D1 - Riproximin, ein neues typ ii ribosom-inaktivierendes protein und seine verwendung - Google Patents

Riproximin, ein neues typ ii ribosom-inaktivierendes protein und seine verwendung

Info

Publication number
DE602006001579D1
DE602006001579D1 DE602006001579T DE602006001579T DE602006001579D1 DE 602006001579 D1 DE602006001579 D1 DE 602006001579D1 DE 602006001579 T DE602006001579 T DE 602006001579T DE 602006001579 T DE602006001579 T DE 602006001579T DE 602006001579 D1 DE602006001579 D1 DE 602006001579D1
Authority
DE
Germany
Prior art keywords
ribosome
riproximine
new type
inactivating protein
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE602006001579T
Other languages
English (en)
Inventor
Cristina Voss
Martin Berger
Carlos Schumacher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Deutsches Krebsforschungszentrum DKFZ
Original Assignee
Deutsches Krebsforschungszentrum DKFZ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deutsches Krebsforschungszentrum DKFZ filed Critical Deutsches Krebsforschungszentrum DKFZ
Publication of DE602006001579D1 publication Critical patent/DE602006001579D1/de
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Botany (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
DE602006001579T 2005-02-04 2006-02-06 Riproximin, ein neues typ ii ribosom-inaktivierendes protein und seine verwendung Expired - Fee Related DE602006001579D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05002356A EP1688429A1 (de) 2005-02-04 2005-02-04 Riproximin, ein neues Typ II Ribosom-inaktivierendes Protein und seine Verwendung
PCT/EP2006/001026 WO2006082098A1 (en) 2005-02-04 2006-02-06 Riproximin , a novel type ii ribosome-inactivating protein and uses thereof

Publications (1)

Publication Number Publication Date
DE602006001579D1 true DE602006001579D1 (de) 2008-08-07

Family

ID=34933591

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006001579T Expired - Fee Related DE602006001579D1 (de) 2005-02-04 2006-02-06 Riproximin, ein neues typ ii ribosom-inaktivierendes protein und seine verwendung

Country Status (9)

Country Link
US (1) US20090137502A1 (de)
EP (2) EP1688429A1 (de)
JP (1) JP2008528045A (de)
AT (1) ATE399178T1 (de)
CA (1) CA2596514A1 (de)
DE (1) DE602006001579D1 (de)
ES (1) ES2309945T3 (de)
MX (1) MX2007008772A (de)
WO (1) WO2006082098A1 (de)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0335476A3 (de) * 1984-02-08 1989-12-13 Cetus Corporation Rekombinante Verfahren für die Herstellung von Ricin-A, Ricin-B, Ricin oder Diphterietoxin-A oder AB'-Fragment, Wirte und Vektoren dafür und Konjugate, die Ricintoxin A-Kette oder Diphterietoxin enthalten
EP0196762A1 (de) * 1985-03-29 1986-10-08 Cetus Corporation Rekombinante Ricinfragmente, diese exprimierende Vektoren und transformierte Wirte, die Modifikation von DNS-Sequenzen und Isolierung von mRNS
DE19526206A1 (de) * 1995-07-18 1997-01-23 Asche Ag Mittel zur Behandlung von Infektionskrankheiten
US6803358B1 (en) * 2000-04-14 2004-10-12 Twinstrand Therapeutics Inc. Ricin-like toxin variants for treatment of cancer, viral or parasitic infections
GB9909796D0 (en) * 1999-04-28 1999-06-23 Plant Bioscience Ltd Pesticidal fumes

Also Published As

Publication number Publication date
EP1846441A1 (de) 2007-10-24
ATE399178T1 (de) 2008-07-15
EP1846441B1 (de) 2008-06-25
JP2008528045A (ja) 2008-07-31
US20090137502A1 (en) 2009-05-28
WO2006082098A8 (en) 2007-09-20
WO2006082098A1 (en) 2006-08-10
CA2596514A1 (en) 2006-08-10
MX2007008772A (es) 2008-03-10
EP1688429A1 (de) 2006-08-09
ES2309945T3 (es) 2008-12-16

Similar Documents

Publication Publication Date Title
DE112007001307A5 (de) Mikrobiologische Herstellung von 3-Hydroxyisobuttersäure
BRPI0519766A2 (pt) proteases Ácidas féngicas
CY1116279T1 (el) Η χρηση των ανθρωπινων κυτταρων προελευσης μυελογενους λευχαιμιας για την εκφραση αντισωματων
HK1224329A1 (zh) 種新型的以蛋白為基礎的治療用分子
ATE557038T1 (de) Herstellung von rekombinantem il-18 bindendem protein
DE602005013819D1 (de) Pyridincarbonsäureamidderivate zur verwendung als antikrebsmittel
DE602006015297D1 (de) 3-azetidincarbonsäure-derivate zur verwendung als immunsuppressiva
ATE512141T1 (de) Verwendung von tetrahydrobenzoxazinen als antioxidantien
CR10852A (es) Compuestos biciclicos y su uso como anti-diabeticos
CY1110860T1 (el) Αναστροφη μεταγραφαση τελομερασης πτηνου
DE602004024609D1 (de) Korrektur von Ausrichtungsfehlern
DE602006004911D1 (de) Gasphasenoxidationskatalysator und dessen Verwendung zur Herstellung von Acrylsäure
DE602006006009D1 (de) Methode zur Herstellung von Acrylsäure
DE602007011897D1 (de) Neue aminoalkohol-substituierte aryldihydroisochinolinone, herstellungsverfahren und ihre verwendung als medikamente
DE602006017918D1 (de) Verfahren zur Herstellung von Telmisartan
DE602006007048D1 (de) Viskositäts- und Zirkulationssteuerung von Fabstoff für den Druck von Linsengussformen
DE502006004941D1 (de) Von hohlprofilen
DE502006008804D1 (de) Neue, langwirksame betamimetika zur behandlung von atemwegserkrankungen
DE602006003108D1 (de) Methode zur Verbesserung der Ausbeute bei der Proteinreinigung mittels Gelfiltrationschromatographie und Arginin
DE602005004215D1 (de) Herstellung von cis-1,4-Polybutadien
DE502005003027D1 (de) Elektrolysezelle zur herstellung von alkalimetall
DE602005015297D1 (de) Verwendung von ozon zur verbesserung des knetvorgangs
ATE507222T1 (de) 1,1-dioxo-thiomorpholinyl-indolyl-methanon- derivate zur verwendung als h3-modulatoren
ATE414796T1 (de) Mittel zur herstellung von leder
ATE539163T1 (de) Auf der verwendung von mva beruhende impfstoffe

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee